Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
91,700,647
-
Share change
-
-2,193,486
-
Total reported value
-
$27,831,887
-
Put/Call ratio
-
9.2%
-
Price per share
-
$0.30
-
Number of holders
-
89
-
Value change
-
-$772,744
-
Number of buys
-
21
-
Number of sells
-
51
Institutional Holders of VBI VACCINES INC CDA - COM NEW (VBIV) as of Q1 2023
As of 31 Mar 2023,
VBI VACCINES INC CDA - COM NEW (VBIV) was held by
89 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
91,700,647 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, BlackRock Inc., STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, Cambridge Investment Research Advisors, Inc., VANGUARD GROUP INC, GENERAL AMERICAN INVESTORS CO INC, NORTHERN TRUST CORP, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
89
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.